Recombinant multi-species oncostatin M/OSM protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine oncostatin M/OSM protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the leukemia inhibitory factor/oncostatin-M (LIF/OSM) family of proteins. The encoded preproprotein is proteolytically processed to generate the mature protein. This protein is a secreted cytokine and growth regulator that inhibits the proliferation of a number of tumor cell lines. This protein also regulates the production of other cytokines, including interleukin 6, granulocyte-colony stimulating factor and granulocyte-macrophage colony stimulating factor in endothelial cells. This gene and the related gene, leukemia inhibitory factor, also present on chromosome 22, may have resulted from the duplication of a common ancestral gene. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Jan 2016]
The Alternative Names of target: OSM,OncoM,Oncostatin-M,Osm,oncostatin M

Target products collectionGo to oncostatin M/OSM products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T19556-Ag-1/ GM-Tg-hg-T19556-Ag-2 Human oncostatin M/OSM protein Human
GM-Tg-rg-T19556-Ag-1/ GM-Tg-rg-T19556-Ag-2 Rat oncostatin M/OSM protein Rat
GM-Tg-mg-T19556-Ag-1/ GM-Tg-mg-T19556-Ag-2 Mouse oncostatin M/OSM protein Mouse
GM-Tg-cynog-T19556-Ag-1/ GM-Tg-cynog-T19556-Ag-2 Cynomolgus/Rhesus macaque oncostatin M/OSM protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T19556-Ag-1/ GM-Tg-felg-T19556-Ag-2 Feline oncostatin M/OSM protein Feline
GM-Tg-cang-T19556-Ag-1/ GM-Tg-cang-T19556-Ag-2 Canine oncostatin M/OSM protein Canine
GM-Tg-bovg-T19556-Ag-1/ GM-Tg-bovg-T19556-Ag-2 Bovine oncostatin M/OSM protein Bovine
GM-Tg-equg-T19556-Ag-1/ GM-Tg-equg-T19556-Ag-2 Equine oncostatin M/OSM protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T19556-Ag-1/ GM-Tg-hg-T19556-Ag-2; GM-Tg-rg-T19556-Ag-1/ GM-Tg-rg-T19556-Ag-2;
GM-Tg-mg-T19556-Ag-1/ GM-Tg-mg-T19556-Ag-2; GM-Tg-cynog-T19556-Ag-1/ GM-Tg-cynog-T19556-Ag-2;
GM-Tg-felg-T19556-Ag-1/ GM-Tg-felg-T19556-Ag-2; GM-Tg-cang-T19556-Ag-1/ GM-Tg-cang-T19556-Ag-2;
GM-Tg-bovg-T19556-Ag-1/ GM-Tg-bovg-T19556-Ag-2; GM-Tg-equg-T19556-Ag-1/ GM-Tg-equg-T19556-Ag-2
Products Name oncostatin M/OSM protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name oncostatin M/OSM
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine oncostatin M/OSM protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.